{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:32Z","timestamp":1740147272359,"version":"3.37.3"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG-15388"],"award-info":[{"award-number":["IG-15388"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13256-017-1443-8","type":"journal-article","created":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T11:17:04Z","timestamp":1505992624000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Delayed response to maintenance therapy after first-line chemotherapy in metastatic intrahepatic cholangiocarcinoma: a case report"],"prefix":"10.1186","volume":"11","author":[{"given":"Roberta","family":"Marciano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Servetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cataldo","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bianco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,26]]},"reference":[{"issue":"1","key":"1443_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","volume":"11","author":"B Blechacz","year":"2017","unstructured":"Blechacz B. Cholangiocarcinoma: Current Knowledge and New Developments. Gut Liver. 2017;11(1):13\u201326.","journal-title":"Gut Liver"},{"key":"1443_CR2","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.jhep.2003.11.030","volume":"40","author":"YH Shaib","year":"2004","unstructured":"Shaib YH, Davila JA, McGlynn K, El-Serag HB. Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatol. 2004;40:472\u20137.","journal-title":"J Hepatol."},{"key":"1443_CR3","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/jnci\/89.18.1360","volume":"89","author":"L Wideroff","year":"1997","unstructured":"Wideroff L, Gridley G, Mellemkjaer L, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360\u20135.","journal-title":"J Natl Cancer Inst."},{"key":"1443_CR4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1023\/A:1013747228572","volume":"12","author":"F Donato","year":"2001","unstructured":"Donato F, Gelatti U, Tagger A, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control. 2001;12:959\u201364.","journal-title":"Cancer Causes Control."},{"key":"1443_CR5","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.cgh.2007.05.020","volume":"5","author":"TM Welzel","year":"2007","unstructured":"Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5:1221\u20138.","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"14","key":"1443_CR6","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira SP, Roughton M, Bridgewater J, ABC-02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010;362(14):1273\u201381.","journal-title":"N Engl J Med"},{"issue":"9980","key":"1443_CR7","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/S0140-6736(14)62004-3","volume":"385","author":"LH Simkens","year":"2015","unstructured":"Simkens LH, van Tinteren H, May A, ten Tije AJ, Creemers GJ, Loosveld OJ, de Jongh FE, Erdkamp FL, Erjavec Z, van der Torren AM, Tol J, Braun HJ, Nieboer P, van der Hoeven JJ, Haasjes JG, Jansen RL, Wals J, Cats A, Derleyn VA, Honkoop AH, Mol L, Punt CJ, Koopman M. Maintenance treatment with capecitabine and bevacizumab in metastatic colorectal cancer (CAIRO3): a phase 3 randomised controlled trial of the Dutch colorectal cancer group. Lancet. 2015;385(9980):1843\u201352.","journal-title":"Lancet"},{"issue":"5","key":"1443_CR8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000098107","volume":"70","author":"R Petrioli","year":"2006","unstructured":"Petrioli R, Paolelli L, Marsili S, Civitelli S, Francini E, Cioppa T, Roviello F, Nettuno R, Intrivici C, Tanzini G, Lorenzi M, Francini G. FOLFOX-4 stop and go and capecitabine maintenance chemotherapy in the treatment of metastatic colorectal cancer. Oncology. 2006;70(5):345\u201350. Epub 2006 Dec 15.","journal-title":"Oncology"},{"issue":"4","key":"1443_CR9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00066-006-1524-x","volume":"182","author":"TB Brunner","year":"2006","unstructured":"Brunner TB, Tinkl D, Grabenbauer GG, Meyer T, Brueckl WM, Sauer R. Maintenance chemotherapy after chemoradiation improves survival of patients with locally advanced pancreatic carcinoma: a retrospective analysis of prospectively recruited patients. Strahlenther Onkol. 2006;182(4):210\u20135.","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1443_CR10","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000444854","volume":"90","author":"J Reure","year":"2016","unstructured":"Reure J, Follana P, Gal J, Evesque L, Cavaglione G, Saint A, Fran\u00e7ois E. Effectiveness and tolerability of maintenance capecitabine administrated to patients with metastatic pancreatic cancer treated with first-line FOLFIRINOX. Oncology. 2016;90(5):261\u20136.","journal-title":"Oncology"},{"issue":"2","key":"1443_CR11","doi-asserted-by":"crossref","first-page":"352","DOI":"10.21037\/jgo.2017.03.06","volume":"8","author":"MK Doherty","year":"2017","unstructured":"Doherty MK, McNamara MG, Aneja P, McInerney E, Moignard S, Horgan AM, Jiang H, Panzarella T, Jang R, Dhani N, Hedley D, Knox JJ. Long term responders to palliative chemotherapy for advanced biliary tract cancer. J Gastrointest Oncol. 2017;8(2):352\u201360.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"1443_CR12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cdd.2013.67","volume":"21","author":"L Bracci","year":"2014","unstructured":"Bracci L, Schiavoni G, Sistigu A, Belardelli F. Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer. Cell Death Differ. 2014;21(1):15\u201325.","journal-title":"Cell Death Differ"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-017-1443-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,21]],"date-time":"2017-09-21T11:17:13Z","timestamp":1505992633000},"score":1,"resource":{"primary":{"URL":"http:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-017-1443-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,26]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s13256-017-1443-8","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2017,9,26]]},"article-number":"273"}}